KURMA PARTNERS enters IO BIOTECH, INC. with 6.82M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 8/21/2023ACC: 0001140361-23-040683
6.82M
Baseline shares
0.00
Direct ownership
0 positions
5.43M
Derivative underlying
3 instruments
3
Security positions
6.82M indirect
Non-Derivative Holdings3
Common Stock
IndirectShares owned4.35M
Common Stock
IndirectShares owned1.85M
Common Stock
IndirectShares owned623.43K
Total
6.82M indirect6.82M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.35M | Indirect |
| Common Stock | 1.85M | Indirect |
| Common Stock | 623.43K | Indirect |
| Total | 6.82M | 6.82M indirect |
Derivative Holdings3
Warrants (Right to Buy)
IndirectUnderlying security
Common Stock
Underlying shares
273.60K
Shares owned
N/A
Exercise price
2.47
Expiration
—
Exercise window
—
Warrants (Right to Buy)
IndirectUnderlying security
Common Stock
Underlying shares
4.35M
Shares owned
N/A
Exercise price
2.47
Expiration
—
Exercise window
—
Warrants (Right to Buy)
IndirectUnderlying security
Common Stock
Underlying shares
812.82K
Shares owned
N/A
Exercise price
2.47
Expiration
—
Exercise window
—
Total
Underlying
5.43M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrants (Right to Buy) Indirect | Common Stock | 2.47 | — | — | 273.60K | N/A |
| Warrants (Right to Buy) Indirect | Common Stock | 2.47 | — | — | 4.35M | N/A |
| Warrants (Right to Buy) Indirect | Common Stock | 2.47 | — | — | 812.82K | N/A |
| Total | 5.43M | 0.00 | ||||